1. Home
  2. NVTS vs TXG Comparison

NVTS vs TXG Comparison

Compare NVTS & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • TXG
  • Stock Information
  • Founded
  • NVTS 2014
  • TXG 2012
  • Country
  • NVTS United States
  • TXG United States
  • Employees
  • NVTS N/A
  • TXG N/A
  • Industry
  • NVTS Semiconductors
  • TXG Biotechnology: Laboratory Analytical Instruments
  • Sector
  • NVTS Technology
  • TXG Industrials
  • Exchange
  • NVTS Nasdaq
  • TXG Nasdaq
  • Market Cap
  • NVTS 1.3B
  • TXG 1.3B
  • IPO Year
  • NVTS N/A
  • TXG 2019
  • Fundamental
  • Price
  • NVTS $6.60
  • TXG $11.73
  • Analyst Decision
  • NVTS Strong Buy
  • TXG Buy
  • Analyst Count
  • NVTS 6
  • TXG 14
  • Target Price
  • NVTS $3.79
  • TXG $14.96
  • AVG Volume (30 Days)
  • NVTS 60.5M
  • TXG 4.9M
  • Earning Date
  • NVTS 08-04-2025
  • TXG 08-07-2025
  • Dividend Yield
  • NVTS N/A
  • TXG N/A
  • EPS Growth
  • NVTS N/A
  • TXG N/A
  • EPS
  • NVTS N/A
  • TXG N/A
  • Revenue
  • NVTS $74,145,000.00
  • TXG $624,662,000.00
  • Revenue This Year
  • NVTS N/A
  • TXG N/A
  • Revenue Next Year
  • NVTS $51.14
  • TXG $6.06
  • P/E Ratio
  • NVTS N/A
  • TXG N/A
  • Revenue Growth
  • NVTS N/A
  • TXG N/A
  • 52 Week Low
  • NVTS $1.52
  • TXG $6.78
  • 52 Week High
  • NVTS $9.17
  • TXG $24.76
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 55.63
  • TXG 69.96
  • Support Level
  • NVTS $6.31
  • TXG $10.63
  • Resistance Level
  • NVTS $7.99
  • TXG $12.11
  • Average True Range (ATR)
  • NVTS 0.86
  • TXG 0.63
  • MACD
  • NVTS -0.20
  • TXG 0.11
  • Stochastic Oscillator
  • NVTS 19.24
  • TXG 86.48

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: